SEOUL, March 2 (Korea Bizwire) — Multinational drugmaker GlaxoSmithKline Plc. (GSK) is staging active marketing activities to promote its shingles vaccine in the South Korean market, but the vaccine is still not selling as well as those produced by a Korean company. GSK’s herpes zoster vaccine Shingrix is famous for its high prevention rate of [...]
SEOUL, May 22 (Korea Bizwire) — South Korea’s top pharmaceutical firm, Samsung Biologics Co., said Friday it has signed a tieup deal with multinational drug maker GlaxoSmithKline Plc. (GSK) to manufacture a GSK biosimilar product. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will commercially produce CSK’s lupus treatment, Benlysta, starting in 2022. The [...]
LONDON and WASHINGTON, Aug. 6 (Korea Bizwire) — GSK and the Sabin Vaccine Institute (Sabin) today announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently [...]